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Kampo medicine has been the primary medical model in Japan until the mid 1800s, regained a prominent role in today’s Japanese
medical system. Today, 148 herbal Kampo formulas can be prescribed under the national health insurance system, allowing
physicians to integrate Kampo in their daily practice. This article aims to provide information about the extent to which Kampo is
now used in clinics throughout Japan and about physician’s current attitudes toward Kampo. We used the results of a 2008 survey
that was administered to physicians throughout Japan (n = 684). The data showed that 83.5% of physicians currently use Kampo
in the clinic, although the distribution of physicians who use Kampo diﬀer widely depending on the specialty and provided a
breakdown of Kampo usage by specialty. It will be interesting to see how each specialty incorporates Kampo into its respective ﬁeld
as Kampo continues to play a pertinent role in Japanese medical system.
1.Introduction
Since the 1970s, there has been a growing interest in the use
of complementary and alternative medicine (CAM) around
the world. CAM includes all medical and health care-related
practicesthat arenot considered part ofWestern medicine or
allopathic medicine, such as acupuncture, moxibustion, and
traditionalChinese medicine. Thereasonsforthedeveloping
interest in CAM are complex but likely include concerns
over the rising price of health care, the growing wariness
in the patient population towards the safety and eﬃcacy of
medications, and the limited eﬀectiveness of biomedicine for
thetreatmentofchronicdiseasesanddiseasesforwhichthere
are no ﬁndings upon performing the physical examination.
Allopathic medicine has been highly successful up to this
point in treating infectious diseases, which have been the
majority of health concerns faced by patients until the 1970s.
As people now begin to see the limitations of Western med-
icine, they are rediscovering traditional medicine in search of
new solutions and treatments.
Japanese medical system is unique around the world
becauseit is theonly countrywherewe cansee the integrated
use of modern and traditional medicine in daily practice.
Today’s Japanese physicians, who are all trained in allopathic
medical schools, use biomedicine and traditional Japanese
medicine (Kampo medicine) together in the clinic and even
in the university hospital in combination with high tech
medicine. Kampo medicine, which originates from ancient
China, had been Japanese primary health care system for
over 1500 years prior to the Meiji Restoration (1868–1912).
It was not until the late 1700s, with the introduction of
anatomy and surgery along with the successful use of the
smallpox vaccine, that Western medicine began to take hold
and develop into its own separate medical system in Japan.
Both systems developed independently, although Kampo
remained the system of choice until the late 1800s. In
1874, the government passed the Medical Care Law, which
called for the adoption of the German model of health
care and the abrogation of Kampo medicine. All Japanese
physicians from that time onward were now only trained2 Evidence-Based Complementary and Alternative Medicine
in allopathic medicine and Kampo practitioners were no
longer considered legitimate medical professionals by the
government. However, despite the government’s attempts to
eliminate Kampo medicine, early 20th century physicians
continued to work towards reinstating Kampo as an oﬃcial
part of Japanese health care system. In 1967, the ﬁrst four
Kampo formulas were approved for coverage under the
national health insurance system. As of today, this number
has increased to 148 approved prescriptions. In 2001, the
Ministry of Education, Science, and Technology also set
new guidelines that called for the incorporation of Kampo
medicine into the core curriculum of Japanese medical
schools, and as of 2005, all medical schools in Japan have
made the necessary changes to their curricula.
Today, Kampo is seen as a well-integrated component
of Japanese medical system. Previous studies, such as those
c a r r i e do u tb yF u j i w a r ae ta l .[ 1], Yamashita et al. [2], and
Watanabe et al. [3] that focus on the status of CAM in
Japan have shown that up to 82% of Japanese physicians are
familiar with the term “Kampo” and 78% use it in practice.
This article evaluates the extent of Kampo’s integration in
daily practice. We predict that there has been an increase
in the knowledge and usage of Kampo amongst physicians
and that distribution and attitudes of Kampo diﬀer among
the diﬀerent specialties. This article speciﬁcally provides the
Kampo experience by physicians and a breakdown of Kampo
usage among specialties. By looking at patterns in Kampo
usage for each specialty, we hope to provide insight for
improving Kampo practice in each ﬁeld.
2. Methods
2.1. Sample and Data Collection. The survey of the usage
of Kampo medicine by physicians was sponsored by the
Japan Kampo Medicine Manufacturers Association and
created by a third-party research group, TM Marketing
Inc. An invitation to take the internet-based questionnaire
was sent to 1,800 physicians randomly chosen from 17,164
physicians who agreed to be registered as a potential
responder to the questionnaires by TM Marketing Inc.,
mostly non-Kampo experts who had never exposed to
Kampo education, enrolled to TM Marketing Inc. which
is a commercial contract research organization sponsored
by Japan Kampo Medicine Manufactures Association. The
study samples consisted of physicians practicing through-
out Japan and the ratio of general physicians and hos-
pital physicians reﬂects the ratio of Japan provided by
the Ministry of Health, Labor, and Welfare of Japan
(http://www.mhlw.go.jp/toukei/list/33-20.html). Total 684
physicians answered the questionnaires between August and
September 2008.
Participants were ﬁrst asked general proﬁle questions,
which included age, gender, and specialty. Secondly, the
question was if they use Kampo medicine in daily prac-
tice and for those who responded aﬃrmatively, additional
Kampo-related questions were asked to get a sense of each
participant’s attitudes and beliefs towards Kampo. Ques-
tions, such as why s/he started to prescribe Kampo drugs
and how long s/he has used Kampo in daily practice, the
number of formulas s/he prescribes, and for which diseases
Kampo is prescribed, were asked. The participants were also
queried about their beliefs towards the reliability of Kampo
diagnosis, the eﬀectiveness of Kampo formulas, and the
future of Kampo. Those physicians who responded not to
use Kampo medicine in daily practice were asked for their
reasons not to do so. To compare the indications for Kampo
medicine in a university hospital, we searched the disorders
of 1,691 new patients in the clinic of Center for Kampo
Medicine in Keio University Hospital in 2005 and 2006.
3. Results
3.1. Participants Proﬁle (Table 1). Questionnaire participants
were comprised mainly of physicians working in a hospital
setting (72%), of which 12.9% work in university hospitals,
32.5% in teaching hospitals, and 26.6% in private nonteach-
ing hospitals. The participants varied in age, with 19.6%
(n = 134) of participants being less than 39 years of age
and 5.8% (n = 40) over 60 years. The major age group was
of 40–49 years (n = 310). 92.8% (n = 635) of participants
were male, and 71.5% (n = 489) specialized in one of the
following specialties: internal medicine (n = 232), surgery
(n = 72), psychiatry (n = 56), orthopedics (n = 52),
pediatrics (n = 47), or obstetrics/gynecology (OB/GYN)
(n = 30).
3.2. Kampo in Daily Clinical Practice. Participating physi-
cians were asked whether they use Kampo medicine in some
capacity in their daily practice. Questionnaire results show
that 83.5% of respondents (n = 571) use Kampo in their
practice (Figure 1). Of the specialties surveyed, Kampo was
most commonly used amongst internists (88.8%) and least
commonly used amongst pediatricians (68.1%).
Table 2 shows the average number of Kampo prescrip-
tions used by each specialty. Overall, 41.7% of physicians
responded that they use 1–4 formulas and 30.1% use 5–9
formulasintheclinic.However,usagevariedbyspecialty.For
instance, 9.7% of internists and 7.7% of OB/GYN specialists
responded that they use as much as 25 or more formulas in
the clinic, whereas 73.0% of orthopedic surgeons, 54.1% of
surgeons, 53.1% of pediatricians, and 45.8% of psychiatrists
responded that they typically use only 1–4 formulas.
Physicians were then asked about Kampo use for their
patients (Figure 2): 79.8% responded that their patients
use Kampo medicine along with Western medicine for
treatment. The remaining 20.2% of physicians answered that
their patients use Kampo medicine alone for treatment,
although this also varied by specialty. As much as 44.1% of
OB/GYN patients, for example, take Kampo medicine alone
for treatment.
3.3. Current Attitudes toward Kampo Medicine. When asked
about the importance of Kampo diagnosis (SHO), 47.8%
of physicians overall replied that they relied mainly on
Western diagnosis and 36.1% considered Kampo diagnosis
(SHO) additionally to Western diagnosis (Figure 3). Only
12.4% of physicians gave both diagnosis with equal weight.Evidence-Based Complementary and Alternative Medicine 3
Table 1: Proﬁle of the physicians of this study.
Total
(n = 684)
Internal
medicine
(n = 232)
Pediatrics
(n = 47)
Psychiatry
(n = 56)
OB/GYN
(n = 30)
Surgery
(n = 72)
Orthopedics
(n = 52)
Others
(n = 195)
Age (y/o)
∼39 134 (19.6%) 43 (15.9%) 10 (21.3%) 16 (28.6%) 4 (13.3%) 11 (15.3%) 7 (13.5%) 49 (25.1%)
40∼49 310 (45.3%) 100 (43.1%) 15 (31.9%) 15 (26.8%) 15 (50.0%) 41 (56.9%) 31 (59.6%) 93 (47.7%)
50∼59 200 (29.2%) 78 (33.6%) 18 (38.3%) 21 (37.5%) 7 (23.3%) 18 (25.0%) 11 (21.2%) 47 (24.1%)
60∼ 40 (5.8%) 17 (7.3%) 4 (8.5%) 4 (7.1%) 4 (13.3%) 2 (2.8%) 3 (5.8%) 6 (3.1%)
Sex
Male 635 (92.8%) 212 (91.4%) 40 (85.1%) 50 (89.3%) 27 (90.0%) 70 (100%) 52 (100%) 182 (93.3%)
Female 49 (7.2%) 20 (8.6%) 7 (14.9%) 6 (10.7%) 3 (10.0%) 0 (0%) 0 (0%) 13 (6.7%)
Clinical settings
University hospital 88 (12.9%) 12 (5.2%) 8 (17.0%) 6 (10.7%) 2 (6.7%) 16 (22.2%) 5 (9.6%) 39 (20.0%)
Educational hospital 222 (32.5%) 83 (35.8%) 24 (51.1%) 20 (35.7%) 14 (46.6%) 24 (33.4%) 29 (55.8%) 17 (8.6%)
Noneducational hospital 183(26.6%) 83(35.8%) 5(10.7%) 20(35.7%) 6(20.0%) 21(29.1%) 10(19.2%) 37(19.0%)
Clinic 182 (26.2%) 96 (41.4%) 10 (21.3%) 7 (12.5%) 8 (26.7%) 8 (11.1%) 7 (13.5%) 43 (22.1%)
Others 13 (1.9%) 5 (2.2%) 0 (0%) 3 (5.4%) 0 (0%) 3 (4.2%) 1 (1.9%) 1 (0.5%)
83.5%
88.8%
68.1%
85.7%
86.7%
84.7%
71.2%
82.6%
14.6%
10.8%
27.7%
12.5%
13.3%
15.3%
21.2%
14.9%
1.9%
0.4%
4.3%
1.8%
0%
0%
7.7%
2.6%
0% 20% 40% 60% 80% 100%
Total
(n = 684)
Internal medicine
(n = 232)
Pediatrics
(n = 47)
Psychiatry
(n = 56)
OB/GYN
(n = 30)
Surgery
(n = 72)
Orthopedics
(n = 52)
Others
(n = 195)
Prescribing
Prescribed
Never prescribed
Figure 1: Physicians’ experience of Kampo treatment. Total and each specialist’s experiences of Kampo treatment. Oblique line bar shows
the ratio of physicians who are prescribing Kampo drugs, vertical line bar, the ratio of physicians who have prescribed Kampo drugs before,
dotted bar, the ratio of physicians who have never prescribed Kampo drugs.4 Evidence-Based Complementary and Alternative Medicine
Table 2: The number of Kampo medicine used for patients.
Number of
Kampo drugs
Total
(n = 571)
Internal
medicine
(n = 206)
Pediatrics
(n = 32)
Psychiatry
(n = 48)
OB/GYN
(n = 26)
Surgery
(n = 61)
Orthopedic
(n = 37)
Others
(n = 161)
1∼4 238 (41.7%) 57 (27.7%) 17 (53.1%) 22 (45.8%) 3 (11.5%) 33 (54.1%) 27 (73.0%) 79 (49.1%)
5∼9 172 (30.1%) 66 (32.0%) 10 (31.3%) 15 (31.3%) 11 (42.3%) 15 (24.6%) 4 (10.8%) 51 (31.7%)
10∼14 90 (15.8%) 43 (20.9%) 1 (3.1%) 8 (16.7%) 5 (19.2%) 9 (14.8%) 4 (10.8%) 20 (12.4%)
15∼19 20 (3.5%) 9 (4.4%) 1 (3.1%) 0 (0%) 3 (11.5%) 2 (3.3%) 2 (5.4%) 2 (1.9%)
20∼24 22 (3.9%) 11 (5.3%) 2 (6.3%) 2 (4.2%) 2 (7.7%) 1 (1.6%) 0 (0%) 4 (2.5%)
over 25 29 (5.1%) 20 (9.7%) 1 (3.1%) 1 (2.1%) 2 (7.7%) 1 (1.6%) 0 (0%) 4 (2.5%)
Average
number 7.8 10.4 7.3 6.0 11.3 5.6 4.0 6.2
20.2%
18.2%
23.4%
8.9%
44.1%
13.4%
79.8%
81.8%
76.6%
91.1%
55.9%
86.6%
0% 20% 40% 60% 80% 100%
Total
(n = 571)
Internal medicine
(n = 206)
Psychiatry
(n = 32)
Psychiatrist
(n = 48)
OB/GYN
(n = 26)
Surgery
(n = 61)
Orthopedics
(n = 37)
Others
(n = 161)
Kampo alone
With western medicine
17%
25%
83%
75%
Figure 2: Treatment Style of usual practice of Kampo. Physicians who use Kampo in daily practice answered to the question whether they
prescribe Kampo alone or together with Western medicine. Oblique line bar shows the ratio of physicians who prescribe Kampo drugs alone
when physicians think that Kampo drug is necessary for treatment. Vertical line bar shows the ratio of physicians who prescribe Kampo
drugs together with Western medicine.
In OB/GYN, only 19.2% answered that they give Western
diagnosis only and 57.7% considered SHO additionally to
Western diagnosis.
Physicians were also asked if they would choose Kampo
as a ﬁrst choice treatment for their patients (Figure 4). The
majority of physicians (52.7%) responded that for certain
conditions, they would prescribe Kampo as a ﬁrst-line
treatment, and other 44.5% replied that they use Kampo
to complement Western medicine treatments. Interestingly,
4.9% of surgeons responded that they always oﬀer KampoEvidence-Based Complementary and Alternative Medicine 5
47.8%
41.7%
59.4%
54.2%
19.2%
52.5%
59.5%
51.6%
36.1%
39.8%
31.3%
33.3%
57.7%
32.8%
29.7%
32.3%
12.4%
15.5%
6.3%
8.3%
19.2%
13.1%
8.1%
10.6%
3.7%
2.9%
3.1%
4.2%
3.8%
1.6%
2.7%
5.6%
0% 20% 40% 60% 80% 100%
Total
(n = 571)
Internal medicine
(n = 206)
Pediatrics
(n = 32)
Psychiatry
(n = 48)
OB/GYN
(n = 26)
Surgery
(n = 61)
Orthopedics
(n = 37)
Others
(n = 161)
Based on western medicine diagnosis
SHO additionally to western medicine diagnosis
SHO and western medicine diagnosis together
Western medicine diagnosis additionally to SHO
Figure 3: Selection of Kampo drugs. When Kampo using physicians prescribe Kampo drugs, based on what do they choose Kampo? Data
is shown by ratio of total number of physicians and each specialist. Oblique line bar shows the ratio of physicians who prescribe Kampo
drugs based on Western medicine diagnosis. Vertical line bar shows the ratio of physicians who prescribe Kampo drugs based on SHO
(Kampo diagnosis) additionally to Western medicine diagnosis. Dotted bar shows the ratio of physicians who prescribe Kampo drugs based
onSHOandWesternmedicinediagnosistogether.CrosslinebarshowstheratioofphysicianswhoprescribeKampodrugsbasedonWestern
medicine diagnosis additionally to SHO.
as a ﬁrst-choice treatment, and 76.9% of OB/GYN specialists
replied that they would provide Kampo as the ﬁrst-line of
treatment for certain conditions.
When asked to rank the satisfaction of Kampo treatment
based on a 5-point scale, with a score of 5 being the highest
ranking (Figure 5(a)), 43.5% of physicians gave a score of
4 or 5. This varied slightly across specialties: whereas only
39.3% of internists gave a score of 4 or 5, 59.1% of surgeons
responded that Kampo was highly eﬀective.
Additionally, physicians were asked about the patients’
satisfaction (Figure 5(b)). Totally, 49.1% of physicians
ranked patients’ satisfaction in score 4 or 5, while 70.5% of
surgeons gave a sore of 4 or 5.
Participating physicians were then asked the information
resource of Kampo medicine and reasons for why they began
to use Kampo in their practice (Table 3). Top information
resource was from medical representatives of Kampo phar-
maceutical company (45.7%), followed by other doctors
(44.1%), issues or articles of medical journal (35.2%).
As for the incentive, the top reasons were (1) treatment
with Western medicine alone was not suﬃcient for treating
patients for certain conditions (56.4%) and (2) patients
requested to take Kampo medicine (44.3%).
Physicians who responded that they do not use Kampo
medicine in daily practice (n = 113) were asked the reasons
for not doing so (Table 4). Fifty physicians (44.2%) replied
that they thought Kampo is diﬃcult to use, 39.8% (n =
45) believed that there was not enough evidence currently
available to support the use of Kampo in the clinic, and
32.7% (n = 37) answered that they believe that the eﬀects
o fK a m p oa r et o ow e a kt ob ee ﬀective.
Table 5 shows the top 10 disorders for Kampo choice.
Common cold was the top (46.8%) and followed by
constipation (37.3%), muscle clamp (36.4%), menopausal
syndrome (35.6%), and so forth. All of them were common
disease and not life threatening. When this result was
compared to the cases in the university hospital (Table 6),
atopic dermatitis was the most common disease. Patients6 Evidence-Based Complementary and Alternative Medicine
1.1%
1%
0%
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4.9%
0%
0.6%
52.7%
52.4%
41.7%
76.9%
60.7%
45.9%
51.6%
44.5%
45.6%
50%
56.3%
19.2%
32.8%
54.1%
44.7%
1.2%
0.5%
0%
2.1%
3.8%
0%
0%
1.9%
0.5%
0.5%
0%
0%
0%
0%
0%
1.2%
0% 20% 40% 60% 80% 100%
Total
(n = 684)
Internal medicine
(n = 232)
Pediatrics
(n = 47)
Psychiatry
(n = 56)
OB/GYN
(n = 30)
Surgery
(n = 72)
Orthopedics
(n = 52)
Others
(n = 195)
For all diseases For certain diseases
Supplementary to western medicine For the reduction of western medicine
Others
50%
Figure 4: Indications for Kampo treatment. Oblique line bar shows the ratio of physicians who select Kampo for all diseases as a ﬁrst choice.
Vertical line bar shows the ratio of physicians who select Kampo treatment for certain diseases as a ﬁrst choice. Dotted bar shows the ratio
of physicians who select Kampo treatment as a supplement to Western medicine treatment. Cross line bar shows the ratio of physicians who
use Kampo to reduce the side eﬀects of Western medicine treatment. Right oblique line bar shows the others.
visit university hospital after western treatment with high
expectations. As a fact, atopic dermatitis is the second
most indication for Kampo treatment as cancer is ranked
to number three in the university hospital. After surgery,
cancer patients visited the Kampo clinic in expectation of
prevention of further recurrence or metastasis. Additionally,
patients rely on Kampo treatment for the palliative care.
3.4. Expectations toward Kampo’s Future. The ﬁnal section
of the questionnaire asked all participants (n = 684)
about their expectations for Kampo medicine in the future
(Figure 6). The majority of physicians (62.4%) replied that
more clinical evidence will be necessary before we can see
an increase in the usage of Kampo in the clinic. Another
15.1% responded that the development of a Kampo drug
form, which is easier to administer, would increase its
usage amongst physicians, and 14.3% believed that it will
be necessary to modernize Kampo diagnostic methods, in
particular, develop a new understanding of the concept
of SHO (a patient’s individual diagnostic pattern), before
Kampo can be completely integrated in Japanese current
medical system. Others recommendations, such as changes
in medical education (5.8%) and in better compliance
(1.6%), were also made.
4. Discussion
4.1. Kampo Medicine Is Well Integrated in Japanese Current
Medical System. With the passing of the ﬁrst Medical Care
Law in 1874, all systematic Kampo education was stopped
and only Western medicine was oﬀered at medical schools
and up until the last forty years, this model had remained
the basis for Japanese medical system. Today, we can see
thatJapanesephysiciansrelymainlyonWesternmedicinefor
the diagnosis and treatment of patients. However, although
Western medicine continues to be the principal standard of
medical care, Kampo medicine has also gradually regained
prominence in Japan’s current medical system and the
results of the study strongly suggest that Kampo medicineEvidence-Based Complementary and Alternative Medicine 7
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Internal medicine
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(n = 48)
OB/GYN
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(n = 37)
Others
(n = 161)
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High (+5)
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Figure 5: Satisfaction rate of Kampo treatment by (a) physicians and (b) patients. Satisfaction of Kampo treatment was rated from 1 (low)
to 5 (high) by (a) physicians and (b) patients.
is now a well-integrated part of Japanese medical system.
Today 83.5% of Japanese physicians use Kampo in daily
practice, and of this set, 79.8% use Kampo along with
Western medicine to treat patients. The other 20.2% of the
participants stated that they would prescribe Kampo alone as
the ﬁrst-line choice of treatment. Compared to the results of
previous studies, like that of Imanishi et al. [4] which found
that 70% of the participating physicians use Kampo in their
clinic, there has been an increase in the number of physicians
who practice Kampo.8 Evidence-Based Complementary and Alternative Medicine
Clinical evidence
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20%
(b)
Figure 6: Expectation for Kampo in future. (a) Overall physicians’ expectation. Cross oblique line pie shows the ratio of physicians who
expect clinical evidence of Kampo treatment. Dense pie shows the physicians who expect the understanding of SHO in modern way. Dotted
pie shows the ratio of physicians who expect the development of Kampo drug form (easier to take), grid pie shows the physicians who expect
more Kampo education. Oblique line pie shows the ratio of physicians who expect better compliance of Kampo drugs (less intake or dose
reduction). (b) Expectation for Kampo in each specialty.Evidence-Based Complementary and Alternative Medicine 9
Table 3: Information and reason to have started Kampo treatment
(plural answers).
Information resource (n = 571)
Medical representatives 261 (45.7%)
Recommendation from other doctors 252 (44.1%)
Issues or articles of medical journal 201 (35.2%)
Academic meetings 185 (32.4%)
Request from patients 176 (30.8%)
Seminar by pharmaceutical company 123 (21.5%)
Hospital seminar 50 (8.8%)
Internet 43 (7.5%)
Others 16 (2.8%)
Incentive
More eﬀective than Western medicine 324 (56.4%)
Request from patients 253 (44.3%)
Evidence reported in academic meeting 192 (33.6%)
Limitation of Western medicine 181 (31.7%)
Comprehensive therapy in Kampo 91 (15.9%)
Medical cost reduction 11 (1.9%)
Others 28 (4.9%)
We speculate that there are several factors throughout
Kampo’s history that have allowed for its revival since the
Meiji Restoration in 1867. A combination of physicians’
eﬀorts,advancementsinscienceandresearch,andchangesin
government policy have all played some part in allowing for
Kampo’s integration into Japanese current medical system.
Physicians’ eﬀorts to keep Kampo alive while government
attempted to suppress it played a key role in Kampo’s
survival into contemporary times. In 1934, Dr. Domei
Yakazu and Dr. Keisetsu Otsuka, two prominent physicians
of their generation, formed the Japanese Society of Kampo
Medicine. Through this association, they created a Kampo
training program and teaching materials, such as a Japanese
translation of the Shan hang lun, a n di th e l p e dt os p r e a d
knowledge of Kampo to other physicians. This society would
eventually lead the way to the rise of the Japan Society for
Oriental Medicine, which to this day continues to promote
Kampo medicine through educational programs, academic
meetings,andthroughthepublicationofitsresearchjournal.
Other than the establishment of physician associations, in
1936, Dr. Yakazu and Dr. Otsuka also set up the ﬁrst course
on Kampo Medicine at Takushoku University. Later in 1972,
Dr. Otsuka would also go on to establish the Oriental
MedicineResearchCenteratKitasatoInstitute,aninstitution
open to all interested in studying Kampo medicine including
international students.
At the same time, advancements in science and research
also played a role in allowing for the integration of Kampo
into the current medical system. By 1957, pharmaceutical
companies developed a methodology for mass-producing
standardized Kampo formulas in spray-dry extract form.
Kampo medicine could now be distributed quickly around
the country and sold as an over-the-counter medication
in drug stores. The development of technology, such as
photodioide array detectors and high-performance liquid
chromatography (HPLC), also allowed for the rapid expan-
sion of Kampo research. HPLC analysis, which allows us
to examine how the diﬀerent components of a Kampo
formula interact with one another, is a powerful method for
understanding the molecular mechanisms by which Kampo
formulas act. Due to this method we now understand, for
example, the mechanisms of commonly used formulas like
rikkunshito [5–9] and juzentaihoto [10–13].
Changes in the government policy have also allowed
for Kampo’s integration with modern Japanese medicine.
In 1967, the government accepted the ﬁrst four Kampo
formulas for coverage under the national health insurance
system. By 1976, the number of approved formulas covered
by insurance increased from four to forty-one. This change
in the government policy caused an exponential increase
in Kampo usage all over the country. Now that Kampo
was covered under national insurance, physicians were more
willing to prescribe Kampo formulas to patients. Physicians
now also had more incentive to learn how to eﬀectively
use Kampo medicine as the government has sanctioned it
as a legitimate treatment alternative. The pharmaceutical
industry responded to the change in government policy
by increasing their eﬀorts in research and development
of Kampo products. Between 1976 and 1992, the market
sales of Kampo medicine grew therefore 10-fold. Further,
the government also established the Good Manufacturing
Practice (GMP) law in 1987 to ensure that all Kampo
products are uniform and of high quality. Furthermore, in
2001, the Ministry of Education, Science and Technology
set the ﬁrst guidelines for including Kampo education in
the core curriculum for medical schools around the nation.
A systematic system for Kampo education was seen as
necessaryforensuringthatthefuturegenerationsofJapanese
physicianswouldbeabletointegrateKampointheirpractice
as well. All together, physician eﬀorts, advances in Kampo
research and science, and changes in the government policy
have all allowed for Kampo’s integration into the Japanese
medical system.
4.2. Diﬀerences in Kampo Usage by Specialty. Although
83.5% of Japanese physicians overall use Kampo to some
capacity in daily practice, there are clearly diﬀerences in
usage amongst the diﬀerent specialties. From the results,
we saw that certain aspects of Kampo medicine, such as
the value diﬀerent specialists placed on Kampo diagnosis or
the percentage of patients to whom they prescribe Kampo
formulas, varied greatly depending on the specialty. We
attribute these diﬀerences to the nature of the conditions
commonly seen by each specialty as well as to the history of
Kampo use in each.
The most mentionable diﬀerences in Kampo usage was
within the OB/GYN specialists. Overall, we see higher
usage and a more positive perception of Kampo in this
specialty. 57.7% of OB/GYN specialists answered that they
give equal consideration to Western and Kampo diagnoses
and 44.1% responded that they give Kampo medicine alone
as treatment for their patients. Furthermore, amongst all the10 Evidence-Based Complementary and Alternative Medicine
Table 4: Reasons not to prescribe Kampo drugs (plural answers).
Total
(n = 113)
Internal
medicine
(n = 26)
Pediatrics
(n = 15)
Psychiatry
(n = 8)
OB/GYN
(n = 4)
Surgery
(n = 11)
Orthopdic
(n = 15)
Others
(n = 34)
Diﬃcult to use 50 (44.2%) 10 (38.5%) 7 (46.7%) 3 (37.5%) 1 (25.0%) 5 (45.5%) 4 (26.7%) 20 (58.8%)
Short of clinical
evidences 45 (39.8%) 10 (38.5%) 7 (46.7%) 2 (25.0%) 0 (0%) 5 (45.5%) 7 (46.7%) 14 (41.2%)
Not enough
eﬀectiveness 37 (32.7%) 13 (53.8%) 3 (20.0%) 2 (25.0%) 0 (0%) 3 (27.3%) 6 (40.0%) 9 (26.5%)
Patient’s
unpreferance 24 (21.2%) 3 (11.5%) 8 (53.3%) 2 (25.0%) 1 (25.0%) 4 (36.4%) 0 (0%) 2 (5.9%)
Only Western
medicine is
satisfactory
24 (21.2%) 10 (38.5%) 1 (6.7%) 2 (25.0%) 2 (50.0%) 4 (36.4%) 3 (20.0%) 2 (5.9%)
Others 13 (11.5%) 3 (11.5%) 3 (20.0%) 1 (12.5%) 0 (0%) 1 (9.1%) 1 (6.7%) 4 (11.8%)
Table 5: Top 10 disorders for Kampo choice.
Disease name Treated patients (%)
1 Common cold 46.8
2 Constipation 37.3
3 Muscle clamp 36.4
4 Menopausal syndrome 35.6
5 Bronchitis 34.2
6 gastritis 29.4
7 fatigue 25.4
8 ileus 18.0
9 edema 12.1
10 neurosis 12.1
Table 6: Top 10 disorders in a university hospital (Keio University
Hospital)1691newpatientsinKeioUniversityHospitalin2005and
2006.
Disease name Treated patients (%)
1 Atopic dermatitis 169 (9.0 %)
2 Cold sensation 117 (6.9 %)
3C a n c e r t h e r a p y 9 2 ( 5 . 4 % )
4 Irregular menstruation 89 (5.3 %)
5 Dysmenorrhea 84 (4.9 %)
6 Dermatitis and eczema 61 (3.6 %)
7 Fatigue 47 (2.8 %)
8 Rhinitis 46 (2.8 %)
9 Insomnia 43 (2.5 %)
10 Infertility 40 (2.4 %)
specialties, OB/GYN has the highest percentage of physicians
(76.9%) who have used Kampo for more than 16 years
in daily practice (data not shown). The likely reason for
the extensive use and support for Kampo in OB/GYN
is Kampo’s long history for treating women’s disorders.
Women suﬀering from conditions such as premenstrual
syndrome usually do not present with any ﬁndings upon
physical examination. The symptoms experienced by these
women are often subjective in nature, making it diﬃcult
for physicians to use Western medicine for treatment. As
a result, historically Japanese physicians have preferred to
use Kampo, and pharmaceutical companies and research
institutions have focused their research and development
of Kampo formulas with this in mind. For example, when
the Kampo-drug manufacturer Tsumura & Co. was ﬁrst
established in 1893, the company’s ﬁrst product was for the
treatment of women’s disorders. Since Kampo has a well-
established reputation for eﬀectiveness in treating women’s
disorders, OB/GYN specialists are more inclined to using it
in daily practice.
Kampo usage is also unique amongst surgeons. Like with
OB/GYN the nature of the conditions seen by surgeons
and the history of Kampo usage in the ﬁeld of surgery
have inﬂuenced the way present-day Japanese surgeons use
Kampo. The data show that 54.1% of surgeons use only a
limited number of formulas, that is, one to four, to treat
patients.ThelimitednumberofKampoformulasusedinthis
ﬁeld is probably due to the fact that Kampo is used primarily
for wound care during surgery and for the reduction of
swelling from fractures. At Keio University hospital, 100%
of surgical patients also take Daikenchuto extract, a Kampo
medicine, to accelerate postoperative recovery [14, 15]. The
results also show that surgeons tend to be more supportive
of Kampo’s use: 70.5% ranked Kampo as highly eﬀective
with a score of 4 or 5 (Figure 5(a)), and 4.9% responded
that they always oﬀer Kampo as a ﬁrst-choice treatment as
opposed to a treatment as supplement to Western medicine
(Figure 4). We can only speculate the reasons for why such a
positive perception of Kampo exists in the ﬁeld of surgery.
One reason may be that Kampo has been used in surgery
since the ﬁeld was introduced in Japan in the late 1700s:
as early as 1805, Hanaoka Seishu resected a breast cancer
using Kampo as the world’s ﬁrst general anesthesia. As with
OB/GYN, since Kampo has a well-established reputation in
the ﬁeld of surgery, so present-day surgeons are more likely
to use Kampo in daily practice.
Within internal medicine, we see yet a diﬀerent pattern
of Kampo usage in the clinic. Amongst all the specialties,
internal medicine had the highest number of physicians
(88.8%) who responded that they use Kampo daily inEvidence-Based Complementary and Alternative Medicine 11
practice (Figure 1), and 9.7% of this group replied that they
commonly prescribe 25 or more Kampo formulas (Table 2).
We attribute the high rate of usage and diversity of formulas
used to the fact that internists see the widest variety of
patients. Moreover, in February 1998, the Japanese Society
for Oriental Medicine established Kampo Medicine as a
specialty that physicians can enter after board certiﬁcation.
These specialists often complete their training in internal
medicine before choosing to specialize in Kampo. Thus, our
sample group of internists likely includes physicians who
have chosen to specialize in Kampo. Since Kampo specialists
must know all 148 Kampo prescriptions covered by the
Japanese health insurance, they can use a wider array of
Kampo formulas. This may be another reason why we see
a high rate of usage and diversity of formulas used amongst
internists.
Based on the results of the questionnaire, Kampo med-
icine seems less popular as a treatment option in pedi-
atrics, psychiatry, and orthopedics as compared to OB/GYN,
surgery, and internal medicine. 59.4% of pediatricians,
54.2% of psychiatrists, and 59.5% of orthopedic surgeons
responded that they rely only on Western diagnosis for
treating patients (Figure 3). In addition, the majority of
physicians in these specialties who use Kampo use only 1–
4d i ﬀerent types of formulas (Table 2). We can only speculate
reasons why these trends exist. Perhaps current Western
treatments are suﬃcient enough in these specialties that
physicians do not need to look into alternative treatments
for patients. Furthermore, whereas in OB/GYN or surgery
there has been a long tradition of using Kampo for certain
conditions, the same does not seem to exist for pediatrics,
psychiatry, and orthopedic surgery. Thus, specialists in these
ﬁelds may know less about potential Kampo treatments for
their patients. Another reason is probably the lack of clinical
evidence on the eﬃcacy of Kampo formulas. Pediatricians,
for example, work with a special population of patients.
They may be more hesitant to use Kampo for fear of
unknown side eﬀects in children. Pediatricians must also
take the parents’ wishes into consideration: parents may not
want their children to take herbal medicine if a Western
treatment is available. Children also often refuse to take
bitter-tasting medicine, making it diﬃcult to prescribe
certain undelightful tasting Kampo formulas. However, in
this case, the combined use with ﬂavoured jellies could
help to cover the bitterness of these medications. The same
reasoning may be applied to psychiatry and orthopedic
surgery. In psychiatry, there has only been limited evidence
ontheeﬀectivenessofcombiningKampowithantipsychotics
for patients with schizophrenia. However, the amount of
clinical evidence supporting the use of Kampo in psychiatry
isstillscarce,makingpsychiatristscautiousaboutprescribing
Kampo to their patients. Furthermore, as with pediatrics,
psychiatrists may be hesitant to prescribe Kampo because of
side eﬀects. One such example is with ginkgo, an herb used
in formulas against dementia. In combination with aspirin,
NSAIDs, anticoagulants, or other platelet inhibitors, it has
been shown to signiﬁcantly increase the bleeding tendency
of the patient [16–20]. For these specialties, more clinical
data are necessary before we might see an increase of usage
in these ﬁelds.
4.3. Toward the Modernization of Kampo Medicine. Of the
684 participants, 113 replied that they do not use Kampo
medicine in daily practice. In this subset, 44.2% (n =
50) stated that they found Kampo diﬃcult to use, 39.8%
(n = 45) believed that there was not enough evidence
currently available to support the use of Kampo in the
clinic, and 32.7% (n = 37) answered that they believe the
eﬀects of Kampo are weak. Questionnaire participants also
suggested that changes in medical education and in Kampo
prescription would be beneﬁcial for the spread of Kampo
use amongst Japanese physicians. The need for clinical
evidence, for improvements in medical education, and for
improvements in Kampo prescription have all have been
long-standing issues Kampo has faced.
Even in 1976 when the government had approved an
additional 37 formulas to be covered under the national
insurance system, members of the government hesitated
because of the lack of clinical evidence on the eﬀectiveness
and eﬃcacy of Kampo formulas, despite data collected by
pharmaceutical companies and research institutions on the
mechanistic action of many Kampo formulas. At present,
it is still diﬃcult for researchers to design randomized
controlled trials (RCTs) given the individualized nature of
Kampo treatments. Randomized clinical trials, which are
the best design for testing the eﬃcacy or eﬀectiveness of a
drug, require standardization of treatment across the patient
population. This is diﬃcult to achieve with Kampo since
Kampo treatments are individualized according to a patient’s
sho pattern and diagnosis. Keio University is currently
developing a data-mining system that collects individual
patient data for analysis to overcome this challenge [21].
The need for comprehensive Kampo education has been
another problem that has limited the widespread use of
Kampo in clinics. As physicians have indicated in the
questionnaire,manyfeelthatpresent-dayphysicians,whodo
not use Kampo in the clinic, do not use Kampo because they
do not have a comprehensive understanding of Kampo diag-
nosis or of how to use Kampo formulas eﬀectively(Figure 6).
Unfortunately this remains as a residual eﬀect of the Meiji
government’s suppression of systematic Kampo education.
Although individual physician eﬀorts were enough to sustain
interest of Kampo in the medical community and allow
for its revival, the modern form of Kampo that was taught
placed less emphasis on the theory behind Kampo. The
change in government policy in 2001, which mandated
the incorporation of Kampo education in medical school
curriculums,isonesteptowardresolvingthisissue.Physician
associations such as the Japan Society for Oriental Medicine
also provide educational programs for interested physicians.
As more physicians are exposed to Kampo medicine at an
earlier stage in their career, this will hopefully provide more
opportunity for these future generations of physicians to
develop a better understanding of sho diagnosis and the use
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Finally, physicians believe that changes in the formula
form and prescription protocol of Kampo formulas would
help to increase usage of Kampo medicine in clinics. Most
Kampo formulas are currently taken in powder form. A
typical prescription requires patients to take these powder
formulas with hot water three times a day for an extended
period of time (weeks to months). Many physicians have
found the powder form diﬃcult to administer and due to
the frequency it needs to be taken, patients might skip some
intakes and this may be why some believe the eﬀects of
Kampo to be weak. Moreover, Japanese physicians believe
that the current prescription protocol is diﬃcult for patients
to adhere because of the frequency and duration for which
patients must take the Kampo medicine. If changes were
madetotheformulaformandprescriptionprotocolofKam-
po medicine to make its appliance more easy, it is possible
that this will inﬂuence more physicians to prescribe Kampo
in the clinic.
4.4. Physicians’ Attitude to CAM in Other Countries. The
ﬁeld of integrative medicine and holistic healthcare has
grown largely in the world. There have been many articles
on the use of complementary and alternative medicine
(CAM) from nation’s point of view. Eisenberg et al. [22]
reported that Americans were spending more in aggregate
on CAM products and services than they were on visits
to conventional primary care doctors. According to a 2004
survey from the Centers for Disease Control and Prevention,
74.6% of U.S. adults acknowledge using some form of
complementary and alternative medicine at some point in
their lives and 62% had used CAM services in the previous
12 months [23]. Commonly used CAM therapies were
nonvitamin, nonmineral, natural products (17.7%), deep
breathing exercises (12.7%), meditation (9.4%), chiropractic
or osteopathic manipulation (8.6%), massage (8.3%), and
yoga (6.1%). Estimated population of traditional botanical
therapy users was only 0.02% of whole nations. This means
people got the nonvitamin, nonmineral, natural products
mainly by themselves and did not visit traditional medicine
experts.
In US, CAM is practiced mainly by nonphysician health
care practitioner and the collaboration is emphasized [24].
This is because most CAM services are not covered by
insurance plans [25]. Also in terms of education, residents
and medical students are taught to understand how to refer
patients to other CAM providers [26].
The situation is diﬀerent in Germany. In Germany, the
overall percentage of individuals with experience in CAM
increased from 52% in 1970 to 73% in 2002 [27]. National
survey of German oﬃce-based physicians in outpatients care
(GPs and specialists) authorized by the National Association
of Statutory Health Insurance showed many modalities of
CAM including acupuncture (37%) and traditional Chinese
medicine (TCM) are used by physicians [28]. Another article
focusing on family practice physicians in Germany showed
that neural therapy, phytotherapy, and acupuncture were the
most commonly used therapy [29].
In Japan, among CAM modalities, only Kampo medicine
is taught to prescribe in medical schools and other CAM
therapies are not educated. This bias is based on the culture
background on the long medical history in Japan. Addition-
ally,onlyKampoandverylimitedindicationsofacupuncture
are covered by national health insurance system. Also in
terms of the quality management [30], Kampo products are
well controlled and quite safe. The quality control of the
purity as well as toxicity is standardized in Japan, following
the Japanese pharmacopoeia and internationally established
regulations for Good Manufacturing Practice (GMP) and
Good Laboratory Practice (GLP). The standardization of
the main components has become possible and this is a
precondition of clinical research [21]. In future, it is possible
that other CAM modalities will be demanded and used by
physiciansifthenationdemandsitandcoveredbyinsurance.
5. Conclusion
Despite recent advances in Kampo’s status in the current
medical system in Japan, Kampo medicine must still mod-
ernize before we see more Japanese physicians use it in their
practice. The two main issues that Kampo currently faces
are (1) the need for clinical evidence to support its eﬃcacy;
(2) improvement of clinical training and Kampo education
programs. Although Kampo is widely used today, the
majority of physicians (62.4%) believe that clinical evidence
will be necessary before more physicians can support the
use of Kampo in the clinic. This would be of particularly
high impact for those specialties, such as psychiatry or
orthopedics, which do not have a history of Kampo use for
their specialties. Improvements in Kampo medical education
would help Kampo gain more ground amongst physicians.
44.2% of physicians who currently do not use Kampo in the
clinic responded that they felt that Kampo was diﬃcult to
use. If improvements to Kampo medical education are made
such that medical professionals can begin to practice Kampo
diagnosis and treatment at an earlier point in their careers,
Kampocanbebetterintegratedintheirpracticeinthefuture.
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